OICR

Our strategic partner: Ontario Institute for Cancer Research (OICR)

Established by OICR to better enable the commercial translation of OICR and Ontario oncology innovations, FACIT is OICR’s strategic partner for technology transfer, partnerships and collaborations.

OICR is a translational cancer research institute –a centre of excellence that moves Ontario to the forefront of discovery and innovation in oncology research and ensures the effective knowledge transfer of research findings.

Translational Research Priorities

OICR’s unique translational research model leverages Ontario’s strengths in discovery research and translational medicine to maximize impact of prevention, screening and treatment for cancer patients.

1
Therapeutic
Discovery

Find new ways to treat difficult cancers.

2
Clinical
Development

Use personalized medicine to optimize patient treatment decisions.

3
Population
Health

Improve cancer care through innovation in prevention, diagnostics, screening and treatment delivery.

 

Supporting more than 1,600 researchers, clinician scientists, research staff and trainees, OICR’s research includes small molecules, biologics, stem cells, imaging, genomics, informatics and bio-computing, pathology, high impact clinical trials and health outcomes.

National & International Leadership Role

OICR networks in Ontario, Canada and internationally. This is facilitated by being headquartered in downtown Toronto’s Discovery District. Toronto has Canada’s largest concentration of scientific research and is among the top three in North America in terms of its bioscience cluster.

For more information on OICR, visit www.oicr.on.ca